Living Copolymer-Protein/Peptide Hybrids for Biomedical Applications
申请人:Raja Krishnaswami
公开号:US20110262991A1
公开(公告)日:2011-10-27
Water soluble polymers having formula I: Y-(L
1
)
ni
-(C(O))
n2
—(R
1
)
n3
—R
2
are claimed. The polymers may contain multiple water soluble, immunogenicity reducing moieties and multiple active moieties. The polymers may be linked to a protein, or a peptide having up to twelve amino acids.
MANO MATSUHIKO; SEO TAKUJI; IMAI KIN-ICHI, CHEM. AND PHARM. BULL., 1980, 28, NO 9, 2720-2733
作者:MANO MATSUHIKO、 SEO TAKUJI、 IMAI KIN-ICHI
DOI:——
日期:——
ASSAY FOR PLASMA CELL ASSOCIATED DISEASE
申请人:The Binding Site Group Limited
公开号:EP3631452A1
公开(公告)日:2020-04-08
US9242010B2
申请人:——
公开号:US9242010B2
公开(公告)日:2016-01-26
[EN] LIVING COPOLYMER PROTEIN/PEPTIDE HYBRIDS FOR BIOMEDICAL APPLICATIONS<br/>[FR] HYBRIDES DE COPOLYMÈRES PROTÉINE/PEPTIDE VIVANTS DESTINÉS À DES APPLICATIONS BIOMÉDICALES
申请人:UNIV CITY
公开号:WO2009140683A1
公开(公告)日:2009-11-19
Water soluble polymers having formula I: Y-(L1)ni-(C(O))n2-(R1)n3-R2 are claimed. The polymers may contain multiple water soluble, immunogenicity reducing moieties and multiple active moieties. The polymers may be linked to a protein, or a peptide having up to twelve amino acids.